Gelita has opened a research laboratory located in Frankfurt, Germany dedicated to developing bioactive collagen peptides for cosmetics and other industries.
The facility will optimise microorganisms that can “produce almost unlimited varieties of organic compounds”, it said.
The initial focus is on proteins for the food and cosmetics industries and companies in the pharmaceutical and medical sectors.
"Biotechnology overcomes the limitations of conventional manufacturing processes,” said laboratory manager Dr. Christoph Schorsch (pictured, left).
“Biotechnologically produced proteins enable us to manufacture alternatives of consistently high quality and with optimized properties - in some cases even more resource-efficiently and sustainably than by conventional means,” he added.
Gelita hopes to receive applications from well-trained, experienced specialists.
"As a fast-growing, innovation-driven company, we offer career starters and professionals diversified tasks in a young, friendly team as well as a wide range of development opportunities," said Schorsch.
Dr Sven Abend (pictured, right), CEO of Gelita, said: "Investing in Gelita's Biotech Hub is a clear commitment to biotechnology, a key and future-oriented 21st-century technology that offers enormous innovation potential. It allows us to meet the growing demand of international markets sustainably and with new offers."
